New and evolving rare diseases research programs at the national institutes of health

Public Health Genomics

Volumn 16, Issue 6, 2013, Pages 259-267

  Groft, S C ^a   Rubinstein, Y R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biospecimens; Common data elements; Orphan drugs; Patient advocacy groups; Patient registries; Rare and genetic diseases research; Research network; Undiagnosed diseases

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CLINICAL DATA REPOSITORY; CLINICAL RESEARCH; DATA BASE; DISEASE REGISTRY; DRUG EFFICACY; DRUG SCREENING; DRUG TOXICITY; EDUCATION PROGRAM; FINANCIAL MANAGEMENT; FUNDING; GENETIC DISORDER; HOSPITAL; HUMAN; INFORMATION CENTER; INTERVENTION STUDY; MEDICAL EDUCATION; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; NEGLECTED DISEASE; PATIENT ADVOCACY; POINT OF CARE TESTING; PRIORITY JOURNAL; RARE DISEASE; RESEARCH PRIORITY; THERAPY EFFECT; TRANSLATIONAL RESEARCH; COOPERATION; DRUG INDUSTRY; FACTUAL DATABASE; PUBLIC-PRIVATE PARTNERSHIP; REGISTER; UNITED STATES;

BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; DATABASES, FACTUAL; DRUG INDUSTRY; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); PUBLIC-PRIVATE SECTOR PARTNERSHIPS; RARE DISEASES; REGISTRIES; RESEARCH SUPPORT AS TOPIC; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84899940552     PISSN: 16624246     EISSN: 16628063     Source Type: Journal    
DOI: 10.1159/000355929     Document Type: Article

References (29)

1. Orphan Drug Act, Public Law 97-414, January 4, 1983.
2. Health Promotion and Disease Prevention Amendments of 1984, Public Law 98-551, October 30, 1984.
3. Collins FS: Reengineering translational science: the time is right. Sci Transl Med 2011; 3: 90cm17.
4. National Institutes of Health: Research portfolio online reporting tools (RePORT): NIH RePORTER. http://projectreporter.nih.gov/ reporter.cfm.
5. National Institutes of Health: Estimates of funding for various research, condition, and disease categories (RCDC). Categorical spending. http://report.nih.gov/categorical-spending.aspx.
6. National Institutes of Health: Research, condition, and disease categories (RCDC): project listing by category-rare diseases. http:// report.nih.gov/categorical-spending-project-listing.aspx?FY=2012&ARRA= N&DCat=Rare Diseases.
7. National Institutes of Health: Research, condition, and disease categories (RCDC): project listing by category-orphan drugs. http:// report.nih.gov/categorical-spending-project-listing.aspx?FY=2012&ARRA=N&DCat =OrphanDrugs.
8. The NIH Common Fund Program. http:// commonfund.nih.gov/index.aspx.
9. NIH Intramural Research Program: Our research changes lives. http://irp.nih.gov/ourresearch/ principal-investigators/focus.
10. NIH Clinical Center: Bench-to-Bedside Research Program. http://clinicalcenter.nih. gov/ccc/btb/.
11. Gahl WA, Tifft CJ: The NIH Undiagnosed Diseases Program: lessons learned. JAMA 2011; 305: 1904-1905.
12. Gahl WA, Boerkoel CF, Boehm M: The NIH Undiagnosed Diseases Program: bonding scientists and clinicians. Dis Model Mech 2012; 5: 3-5.
13. National Human Genome Research Institute: Undiagnosed Diseases Program. http://www. genome.gov/27544402.
14. Griggs RC, Batshaw M, Dunkle M, Gopal-Srivastava R, Kaye E, Krischer J, Nguyen T, Paulus K, Merkel PA; Rare Diseases Clinical Research Network: RDCRN Clinical research for rare disease: opportunities, challenges, and solutions. Mol Genet Metab 2009; 96: 20-26.
15. National Center for Advancing Translational Sciences: Rare diseases clinical research network. http://rarediseases.info.nih.gov/research/ pages/41/rare-diseases-clinical-research-programRDCRN.
16. National Center for Advancing Translational Sciences: Genetic and rare diseases information center. http://rarediseases.info.nih.gov/ GARD/Default.aspx.
17. Forrest CB, Bartek RJ, Rubinstein Y, Groft SC: The case for a global rare-diseases registry. Lancet 2011; 377: 1057-1059.
18. Grady C, Rubinstein YR, Groft SC: Informed Consent and patient registry for the rare disease community. Contemp Clin Trials 2012; 33: 3-4.
19. Rubinstein YR, Groft SC: Driving interest in consolidating resources for the creation of a global rare disease patient registry. Contemp Clin Trials 2010; 31: 393.
20. Johnson SB, Whitney G, McAuliffe M, Wang H, McCreedy E, Rozenblit L, Evans, CC: Using global unique identifiers to link autism collections. J Am Med Inform Assoc 2010; 17: 689-695.
21. US National Library of Medicine: NIH common data element resource portal. http://cde. nih.gov.
22. Rubinstein YR, Groft SC, Bartek R, Brown K, Christensen RA, Collier E, Farber A, Farmer J, Ferguson JH, Forrest CB, Lockhart NC, Mc-Curdy KR, Moore H, Pollen GB, Richesson R, Miller VR, Hull S, Vaught J: Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB). Contemp Clin Trials 2010; 31: 394-404.
23. Rubinstein YR, Groft SC, Chandros SH, Kaneshiro J, Karp B, Lockhart NC, Marshall PA, Moxley RT 3rd, Pollen GB, Miller VR, Schwartz J: Informed consent process for patient participation in rare disease registries linked to biorepositories. Contemp Clin Trials 2012; 33: 5-11.
24. McKew JC, Pilon AM: NIH TRND program: successes in preclinical therapeutic development. Trends Pharmacol Sci 2013; 34: 87-89.
25. National Center for Advancing Translational Sciences: FAQ about Bridging Interventional Development Gaps (BrIDGs) program. http://www.ncats.nih.gov/about/faq/bridgs/ bridgs-faq.html.
26. National Institutes of Health: NIH funds development of tissue chips to help predict drug safety. http://www.nih.gov/news/health/ jul2012/ncats-24.htm.
27. National Center for Advancing Translational Sciences: 2012 tissue chip project award. http://www.ncats.nih.gov/tissue-chipawards2012. html.
28. Colvis CM, Devaney S, Brady LS, Hudson KL: Partnering for therapeutics discovery. Clin Pharmacol Ther 2013; 93: 24-25.
29. National Center for Advancing Translational Sciences: Library of industry-provided agents. Discovering new therapeutic uses for existing compound program. http://www.ncats.nih. gov/research/reengineering/rescue-repurpose/ therapeutic-uses/directory.html.